Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea · Delayed Price · Currency is KRW

11,740

+10 (0.09%)

Last updated: Apr 29, 2026, 2:10 PM KST

0.60% (1Y)

Market Cap	216.82B
Revenue (ttm)	255.21B
Net Income (ttm)	13.60B
Shares Out	18.48M
EPS (ttm)	857.41
PE Ratio	13.68
Forward PE	11.81
Dividend	300.00 (2.82%)
Ex-Dividend Date	Dec 29, 2025

Volume	66,064
Average Volume	61,465
Open	11,730
Previous Close	11,730
Day's Range	11,580 - 11,840
52-Week Range	9,990 - 13,210
Beta	0.15
RSI	72.19
Earnings Date	Apr 30, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1978

Employees 623

Stock Exchange Korea Stock Exchange

Ticker Symbol 016580

Full Company Profile

Financial Performance

In 2025, Whan In Pharm's revenue was 255.21 billion, a decrease of -1.69% compared to the previous year's 259.60 billion. Earnings were 13.60 billion, a decrease of -41.85%.

Financial Statements

News

There is no news available yet.